| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |